Physician profile
Philippe G Lopez
NPI 1497740591
$1,133.20
in general payments reported to CMS, 2019-2025
11 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $119 · 2022: $69.95 · 2023: $423 · 2024: $326 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $346.27 | 2020-2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $168.88 | 2022-2025 | Breztri, Fasenra, Tezspire |
| Harmony Biosciences LLC | $154.87 | 2023-2024 | Wakix |
| Abiomed | $144.83 | 2023 | Impella |
| Genzyme Corporation | $87.70 | 2022-2023 | |
| Grifols USA, LLC | $71.90 | 2023-2025 | Prolastin-C Liquid |
| Glaxosmithkline, LLC. | $54.62 | 2023-2025 | Nucala, Arexvy, Shingrix |
| Philips North America LLC | $43.38 | 2024-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| United Therapeutics Corporation | $31.99 | 2025 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $15.97 | 2024 | |
| Axsome Therapeutics, INC. | $12.79 | 2023 | Sunosi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philippe Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.